In TCGA database, BTG3 expression was higher in female than male cancer patients, T1-2 than T3-4, and adenocarcinoma than squamous cell carcinoma patients (Figure 2B, p < 0.05). This evidence concerns the gene BTG3 and adenocarcinoma.